Sign In
Buy HUM
$327.54
+6.66 (+2.08%)
At Close: Jun 03, 2026
Cerity Partners LLC Has $9.03 Million Stake in Humana Inc. $HUM
03:50am, Friday, 12'th Dec 2025
Cerity Partners LLC lowered its position in shares of Humana Inc. (NYSE: HUM) by 6.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fu
Humana Healthy Horizons in Oklahoma Selects Six Nonprofits to Receive Community Impact Awards
11:11am, Wednesday, 10'th Dec 2025
OKLAHOMA CITY--(BUSINESS WIRE)--Humana Healthy Horizons in Oklahoma selects six nonprofits for community impact awards to address health-related social needs.
Federated Hermes Inc. Acquires 57,680 Shares of Humana Inc. $HUM
04:32am, Wednesday, 10'th Dec 2025
Federated Hermes Inc. grew its stake in Humana Inc. (NYSE: HUM) by 69.3% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1
Ardsley Advisory Partners LP Acquires Shares of 50,000 Humana Inc. $HUM
03:25am, Wednesday, 10'th Dec 2025
Ardsley Advisory Partners LP bought a new position in shares of Humana Inc. (NYSE: HUM) in the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor bough
Humana (HUM) Up 0.8% Since Last Earnings Report: Can It Continue?
12:32pm, Friday, 05'th Dec 2025
Humana (HUM) reported earnings 30 days ago. What's next for the stock?
Humana, Mark Cuban's Cost Plus Drugs Working On Partnership
03:35pm, Thursday, 04'th Dec 2025
Humana, one of the nation's largest health insurers for older adults, and Mark Cuban's Cost Plus Drugs are discussing ways to partner to lower the cost of prescription drugs for U.S. employers.
First Look: Insurers, Auto Rules, AI and Fed Jitters
07:38am, Thursday, 04'th Dec 2025
Stock News Insurers under pressure, prior auth pledges stall: UnitedHealth Group (UNH) and peers Cigna (CI), Humana (HUM), CVS Health (CVS) and Elevance Health
Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for 47% of all Medicare Advantage enrollees This latest
Berman Tabacco Announces Investigation of Humana, Inc. (NYSE:HUM)
03:31pm, Tuesday, 02'nd Dec 2025
BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving Humana, Inc (“Humana”)
Humana (NYSE:HUM) Stock Acquired Rep. Lisa C. McClain
02:06am, Thursday, 27'th Nov 2025
Representative Lisa C. McClain (R-Michigan) recently bought shares of Humana Inc. (NYSE: HUM). In a filing disclosed on November 21st, the Representative disclosed that they had bought between $1,001
Humana Inc. (NYSE:HUM) Given Consensus Rating of “Hold” by Analysts
04:41am, Wednesday, 26'th Nov 2025
Shares of Humana Inc. (NYSE: HUM - Get Free Report) have been assigned an average recommendation of "Hold" from the nineteen analysts that are covering the firm, Marketbeat reports. Two equities resea
Berman Tabacco Announces Investigation of Humana, Inc. (NYSE:HUM)
03:59pm, Monday, 24'th Nov 2025
BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving Humana, Inc (“Humana”)
AXQ Capital LP Acquires 2,166 Shares of Humana Inc. $HUM
04:08am, Saturday, 22'nd Nov 2025
AXQ Capital LP lifted its holdings in Humana Inc. (NYSE: HUM) by 98.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fi
New Survey Offers Important Insights into How Medicare Advantage Beneficiaries Use and Value Their Supplemental Benefits
09:00am, Thursday, 20'th Nov 2025
LOUISVILLE, Ky.--(BUSINESS WIRE)--A recent study conducted by Humana Healthcare Research, with strategic input from researchers at the University of Pennsylvania, reveals key insights into how Medicar
Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
07:30am, Thursday, 20'th Nov 2025
HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it ha
